Heavy marijuana users show increased serum apolipoprotein C-III levels: evidence from proteomic analyses

被引:14
作者
Jayanthi, S.
Buie, S.
Moore, S. [3 ]
Herning, R. I.
Better, W.
Wilson, N. M.
Contoreggi, C. [2 ]
Cadet, J. L. [1 ]
机构
[1] NIDA, Mol Neuropsychiat Branch, Intramural Res Program, NIH,Biomed Res Ctr, Baltimore, MD 21224 USA
[2] NIDA, Off Clin Director, Intramural Res Program, NIH,Biomed Res Ctr, Baltimore, MD 21224 USA
[3] Ciphergen Biosyst, Fremont, CA USA
关键词
cannabis; apolipoproteins; protein profiling; cerebrovascular and cardiovascular risk factors; LOW-DENSITY LIPOPROTEINS; CHOLESTEROL-METABOLISM; OVERWEIGHT PATIENTS; ALZHEIMERS-DISEASE; MARIHUANA SMOKING; MASS-SPECTROMETRY; PROSTATE-CANCER; ANGINA-PECTORIS; RISK-FACTORS; CANNABIS;
D O I
10.1038/mp.2008.50
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Marijuana (MJ) is the most commonly used illicit drug in the United States. Its abuse is associated with cognitive dysfunctions and increased resistance to blood flow in the cerebral vasculature. In addition, MJ abuse is associated with increased risks of potentially serious cardiovascular disorders. In the present study, we used the protein chip platform based on surface-enhanced laser desorption/ionization time-of-flight mass spectroscopy (SELDI-TOF-MS) to test the possibility that MJ abuse might be associated with changes in serum protein levels. Indeed, MJ users showed significant increases in three protein peaks, which were identified as three isoforms of apolipoprotein (apo) C-III. Immunoprecipitation using an apoC-III antibody also validated the identification of the proteins. Marijuana-induced increases in apoC-III levels might occur through chronic stimulation of hepatic cannabinoid receptors (CB1 and/or CB2) by its active ingredient, Delta(9)tetrahydrocannibol (THC). Thus, chronic MJ abuse might cause increased transcription and/or translation of apoC-III in the liver with corresponding changes reflected in the plasma of these patients. In any case, because apoC-III is a cardiovascular risk factor, the increased levels observed in MJ users might explain, in part, the cardiac and cerebral abnormalities reported in these patients. Molecular Psychiatry (2010) 15, 101-112; doi: 10.1038/mp.2008.50; published online 13 May 2008
引用
收藏
页码:101 / 112
页数:12
相关论文
共 68 条
[1]  
Adam BL, 2002, CANCER RES, V62, P3609
[2]  
Adams IB, 1996, ADDICTION, V91, P1585, DOI 10.1111/j.1360-0443.1996.tb02264.x
[3]  
ARONOW WS, 1975, CLIN PHARMACOL THER, V17, P549
[4]   EFFECT OF MARIHUANA AND PLACEBO-MARIHUANA SMOKING ON ANGINA-PECTORIS [J].
ARONOW, WS ;
CASSIDY, J .
NEW ENGLAND JOURNAL OF MEDICINE, 1974, 291 (02) :65-67
[5]   Marijuana as a trigger of cardiovascular events: Speculation or scientific certainty? [J].
Aryana, Arash ;
Williams, Mark A. .
INTERNATIONAL JOURNAL OF CARDIOLOGY, 2007, 118 (02) :141-144
[6]   MARIHUANA SMOKING - CARDIOVASCULAR EFFECTS IN MAN AND POSSIBLE MECHANISMS [J].
BEACONSFIELD, P ;
GINSBURG, J ;
RAINSBURY, R .
NEW ENGLAND JOURNAL OF MEDICINE, 1972, 287 (05) :209-+
[7]   CARDIOVASCULAR AND METABOLIC CONSIDERATIONS IN PROLONGED CANNABINOID ADMINISTRATION IN MAN [J].
BENOWITZ, NL ;
JONES, RT .
JOURNAL OF CLINICAL PHARMACOLOGY, 1981, 21 (8-9) :S214-S223
[8]   Dose-related neurocognitive effects of marijuana use [J].
Bolla, KI ;
Brown, K ;
Eldreth, D ;
Tate, K ;
Cadet, JL .
NEUROLOGY, 2002, 59 (09) :1337-1343
[9]  
Cadet JL, 2006, METH MOLEC MED, V123, P255
[10]   CHANGING RELATIVE PROPORTIONS OF APOLIPOPROTEINS-102 AND APOLIPOPROTEINS-103 OF VERY LOW-DENSITY LIPOPROTEINS IN HYPERTRIGLYCERIDEMIA [J].
CARLSON, LA ;
BALLANTYNE, D .
ATHEROSCLEROSIS, 1976, 23 (03) :563-568